Lv41
560 积分 2024-04-11 加入
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
6天前
已完结
Association between very high HDL-C levels and mortality: A systematic review and meta-analysis
20天前
已完结
Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors
24天前
已完结
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?
24天前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
24天前
已完结
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial
1个月前
已完结
How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
3个月前
已完结
α-Synuclein pathology as a target in neurodegenerative diseases
4个月前
已完结
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies
5个月前
已完结
Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development
5个月前
已完结
皖公网安备34019202002308
